A Post marketing study to assess the safety and efficacy of Capixyl Lotion (5%) in patients with Male Pattern Hair Loss

Open label, Multicenter, prospective study to evaluate the efficacy and safety of Capixyl lotion (5%) in subjects with MPHL (Male Pattern Hair Loss)

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2013/10/004104

Enrollment

Registered

2013-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Capixyl Lotion (5%): 1 ml once daily for 4 months Topical application Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy volunteers suffering from MPHL (18-45 yrs). 2.For Male volunteers MPHL of grade II-IV (Norwood classification) 3.As per the Trichoscopy report, -Anisotrichosis >20% 4.Subjects must comply with the protocol.

Exclusion criteria

Exclusion criteria: 1.Non pattern hair loss 2.Thyroid related conditions 3.Other possible pathologies contributing to hair loss 4.Patient on Ketoconazole /Topical minoxidil / Finasteride or any other hair growth therapy 5.Not able to comply to protocol

Design outcomes

Primary

Measure	Time frame
1. Trichoscopy 2. Photographic Assessment 3. Patients Self Assessment 4. Subject Observation on Cosmetic acceptability and Ease of application 5. Patient complianceTimepoint: 1. Trichoscopy- Baseline and after 4 months. 2. Photographic Assessment- Visit 1, Visit 2 and Visit 3 3. Patients Self Assessment- Visits 2 and 3	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactDr Amanjit Ahluwalia

Skin, Trichology and Aesthetic Centre

rachitadhurat@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026